The Mainland China Strategies of PAREXEL International

PAREXEL International Corporation is a leading global biopharmaceutical services organization. Through the acquisition of Taiwan–based APEX International Clinical Research Co. in 2007, PAREXEL strengthened its global capability throughout the Asia-Pacific region.

APEX International Clinical Research Co. is the first Taiwan CRO which expands its business to Mainland China. In an interview with Mr. Albert Liou, the founder of APEX, now the Vice Chairman of PAREXEL International, he shares....